isoflurane has been researched along with Parkinson Disease, Secondary in 2 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muravchick, S | 1 |
| Smith, DS | 1 |
| Karlsson, J | 1 |
| Love, RM | 1 |
| Clarke, DJ | 1 |
| Brundin, P | 1 |
2 other studies available for isoflurane and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Parkinsonian symptoms during emergence from general anesthesia.
Topics: Anesthesia Recovery Period; Anesthesia, General; Humans; Isoflurane; Male; Middle Aged; Nitrous Oxid | 1995 |
Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones.
Topics: Anesthetics, Combined; Anesthetics, Inhalation; Animals; Antioxidants; Behavior, Animal; Brain Tissu | 1999 |